Isthmus Partners LLC Has $12.25 Million Stock Position in Colgate-Palmolive (NYSE:CL)

Isthmus Partners LLC lessened its holdings in shares of Colgate-Palmolive (NYSE:CL) by 0.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 134,757 shares of the company’s stock after selling 197 shares during the quarter. Colgate-Palmolive makes up approximately 1.5% of Isthmus Partners LLC’s investment portfolio, making the stock its 26th largest position. Isthmus Partners LLC’s holdings in Colgate-Palmolive were worth $12,251,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Chicago Partners Investment Group LLC boosted its holdings in shares of Colgate-Palmolive by 16.2% during the 4th quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock worth $591,000 after buying an additional 943 shares during the period. Peak Financial Advisors LLC acquired a new stake in Colgate-Palmolive during the fourth quarter worth approximately $1,315,000. Carrera Capital Advisors boosted its holdings in shares of Colgate-Palmolive by 23.1% during the third quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after acquiring an additional 7,353 shares during the period. Fiduciary Alliance LLC acquired a new position in shares of Colgate-Palmolive in the fourth quarter valued at approximately $4,066,000. Finally, Impact Partnership Wealth LLC bought a new position in shares of Colgate-Palmolive during the fourth quarter worth approximately $803,000. Institutional investors own 80.41% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently weighed in on CL. UBS Group dropped their price target on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research report on Monday, February 3rd. TD Cowen dropped their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, January 8th. JPMorgan Chase & Co. decreased their price target on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. Wells Fargo & Company cut their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. Finally, Royal Bank of Canada reissued a “sector perform” rating and issued a $101.00 target price on shares of Colgate-Palmolive in a report on Wednesday, January 29th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $101.61.

Colgate-Palmolive Price Performance

Shares of NYSE CL opened at $96.84 on Monday. The stock has a fifty day moving average of $88.84 and a 200-day moving average of $95.11. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The stock has a market cap of $78.59 billion, a PE ratio of 27.51, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the previous year, the company posted $0.87 EPS. Equities research analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.07%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 56.82%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.